Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer;Neoadjuvante und adjuvante chemotherapie bei patienten mit fortgeschrittenem peniskarzinom

Urologe - Ausgabe A

Volumn 46, Issue 10, 2007, Pages 1395-1399

  Heidenreich, A ^a   Jakse, G ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chemotherapy; Lymph node metastases; Lymphadenectomy; Metastasectomy; Metastases; Residual tumor resection

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; VINCRISTINE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; CYTOTOXICITY; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; PENIS CANCER; REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; IFOSFAMIDE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; METHOTREXATE; NEOADJUVANT THERAPY; NEOPLASM STAGING; PENILE NEOPLASMS; PENIS; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 35748957127     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1545-9     Document Type: Review

References (26)

1. Ritchie AW, Foster PW, Fowler S (2004) BAUS Section of Oncology. Penile cancer in the UK: clinical presentation and outcome in 1998/99. BJU Int 94(9): 1248-1252
2. Syed S, Eng TY, Thomas CR et al. (2003) Current issues in the management of advanced squamous cell carcinoma of the penis. Urol Oncol 21(6): 431-438
3. Misra S, Chaturvedi A, Misra NC (2004) Penile carcinoma: a challenge for the developing world. Lancet Oncol 5(4): 240-247
4. Derakhshani P, Neubauer S, Braun M et al. (1999) Results and 10-year follow-up in patients with squamous cell carcinoma of the penis. Urol Int 62(4): 238-244
5. Borchers H, Jakse G (2005) Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit. Urologe A 44(6): 657-656
6. Lont AP, Kroon BK, Gallee MP et al. (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177(3): 947-952
7. Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72: 817-819
8. Solsona E, Algaba F, Horenblas S et al. (2004) European Association of Urology. EAU Guidelines on Penile Cancer. Eur Urol 46(1): 1-8
9. Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b): 823-824
10. Pizzocaro G, Piva L, Nicolai N (1996) Treatment of lymphatic metastasis of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan. Arch Ital Urol Androl 68(3): 169-172
11. Hakenberg OW, Nippgen JGW, Froehner M et al. (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98: 1225-1227
12. Bermejo C, Busby JE, Spiess PE et al. (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4): 1335-1338
13. Dexeus FH, Logothetis CJ, Sella A et al. (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5): 1284-1287
14. Haas GP, Blumenstein BA, Gagliano RG et al. (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161(6): 1823-1825
15. Corral DA, Sella A, Pettaway CA et al. (1998) Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 160(5): 1770-1774
16. Soria JC, Fizazi K, Piron D et al. (1997) Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy. Ann Oncol 8(11):1089-1098
17. Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147(3): 630-632
18. Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3): 433-438
19. Kattan J, Culine S, Droz JP et al. (1993) Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy. Urology 42(5): 559-603
20. Otto T, Suhr J, Krege S, Rübben H (2003) Behandlungsoptionen des lokal fortgeschrittenen Peniskarzinoms. Urologe A 42(11): 1466-1469
21. Huang XY, Kubota Y, Nakada T et al. (1999)Intra-arterial infusion chemotherapy for penile carcinoma with deep inguinal lymph node metastasis. Urol Int 62(4): 245-248
22. Roth AD, Berney CR, Rohner S et al. (2000) Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential. Br J Cancer 83: 1637-1642
23. Mitropoulos D, Dimopoulos MA, Kiroudi-Voulgari A et al. (1994) Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma. J Urol 152(4): 1124-1126
24. Skeel RT, Huang J, Manola J et al. (2003) A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study. Cancer Invest 21(1): 41-46
25. Cmelak AJ, Murphy BA, Burkey B et al. (2007) Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial. Head Neck 29(4): 315-24
26. Joerger M, Warzinek T, Klaeser B et al. (2004) Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 63(4): 778-780